First Time Loading...

Cardinal Health Inc
NYSE:CAH

Watchlist Manager
Cardinal Health Inc Logo
Cardinal Health Inc
NYSE:CAH
Watchlist
Price: 104.5607 USD 0.99% Market Closed
Updated: Apr 25, 2024
Section:
 

Wall Street
Price Targets

CAH Price Targets Summary
Cardinal Health Inc

Wall Street analysts forecast CAH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CAH is 118.2472 USD with a low forecast of 96.96 USD and a high forecast of 140.7 USD.

CAH Lowest Forecast
Wall Street Target
96.96 USD
7% Downside
CAH Average Forecast
Wall Street Target
118.2472 USD
13% Upside
CAH Highest Forecast
Wall Street Target
140.7 USD
35% Upside
Lowest
Price Target
96.96 USD
7% Downside
Average
Price Target
118.2472 USD
13% Upside
Highest
Price Target
140.7 USD
35% Upside

CAH Last Price Targets
Cardinal Health Inc

The latest public price target was made on Apr 5, 2024 by Eric Coldwell from Robert W. Baird , who expects CAH stock to rise by 28% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Eric Coldwell
Robert W. Baird
134 USD
Upside 28%
2 weeks ago
Apr 5, 2024
Cardinal Health (CAH) PT Raised to $134 at Baird, 'remains 2024 Best Idea'
StreetInsider
Erin Wright
Morgan Stanley
90 USD
Downside 14%
8 months ago
Aug 15, 2023
Cardinal Health Likely To Post Higher Q4 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts
Benzinga
Tim Anderson
Wolfe Research
127 USD
Upside 21%
1 year ago
Apr 12, 2023
These 3 Health Care Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts
Benzinga
Baird Baird
Robert W. Baird
94 USD
Downside 10%
1 year ago
Feb 8, 2023
CAH Stock: $94 Price Target Received
Pulse 2.0
Unknown Analyst
Credit Suisse
92 USD
Downside 12%
1 year ago
Feb 3, 2023
Credit Suisse Maintains Neutral on Cardinal Health, Raises Price Target to $92
Benzinga
Eric Coldwell
Robert W. Baird
Price Target 134 USD
Upside/Downside 28%
View Source
Erin Wright
Morgan Stanley
Price Target 90 USD
Upside/Downside 14%
View Source
Tim Anderson
Wolfe Research
Price Target 127 USD
Upside/Downside 21%
View Source
Baird Baird
Robert W. Baird
Price Target 94 USD
Upside/Downside 10%
View Source
Unknown Analyst
Credit Suisse
Price Target 92 USD
Upside/Downside 12%
View Source
Cardinal Health Inc Competitors:
Price Targets
1345
China Pioneer Pharma Holdings Ltd
80% Upside
Q
301015
Qingdao Baheal Medical Inc
70% Upside
7476
As One Corp
48% Upside
CAU
Cronos Australia Ltd
178% Upside
1345
China Pioneer Pharma Holdings Ltd
80% Upside
Q
301015
Qingdao Baheal Medical Inc
70% Upside
7476
As One Corp
48% Upside
CAU
Cronos Australia Ltd
178% Upside
A
2784
Alfresa Holdings Corp
2% Upside
000705
Zhejiang Zhenyuan Share Co Ltd
120% Upside
HAEK
Haemato AG
59% Upside
E
4104
Excelsior Medical Co Ltd
16% Downside

Revenue
Forecast

Revenue Estimate
Cardinal Health Inc

For the last 8 years the compound annual growth rate for Cardinal Health Inc's revenue is 9%. The projected CAGR for the next 3 years is 9%.

9%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Cardinal Health Inc

For the last 8 years the compound annual growth rate for Cardinal Health Inc's operating income is -4%. The projected CAGR for the next 3 years is 17%.

-4%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-16%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Cardinal Health Inc

For the last 8 years the compound annual growth rate for Cardinal Health Inc's net income is -17%. The projected CAGR for the next 3 years is 102%.

-17%
Past Growth
102%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

See Also

Summary
CAH intrinsic value, competitors valuation, and company profile.
DCF Valuation
CAH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CAH stock valuation using valuation multiples.
Wall Street Estimates
CAH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CAH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CAH's stock price target?
Price Target
118.2472 USD

According to Wall Street analysts, the average 1-year price target for CAH is 118.2472 USD with a low forecast of 96.96 USD and a high forecast of 140.7 USD.

What is Cardinal Health Inc's Revenue forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Cardinal Health Inc's revenue is 9%. The projected CAGR for the next 3 years is 9%.

What is Cardinal Health Inc's Operating Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Cardinal Health Inc's operating income is -4%. The projected CAGR for the next 3 years is 17%.

What is Cardinal Health Inc's Net Income forecast?
Projected CAGR
102%

For the last 8 years the compound annual growth rate for Cardinal Health Inc's net income is -17%. The projected CAGR for the next 3 years is 102%.

ALPHA SPREAD
Join more than 131,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.